Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencing

Leukemia. 2016 Sep;30(9):1924-6. doi: 10.1038/leu.2016.73. Epub 2016 Apr 5.

Authors

A Pardanani¹, T Lasho¹, E Wassie¹, C Finke¹, D Zblewski¹, C A Hanson², R P Ketterling³, N Gangat¹, A Tefferi¹

Affiliations

¹ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
² Division of Hematopathology, Mayo Clinic, Rochester, MN, USA.
³ Cytogenetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

PMID: 27125206
DOI: 10.1038/leu.2016.73

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Female
High-Throughput Nucleotide Sequencing / methods
Humans
Hypereosinophilic Syndrome / classification*
Hypereosinophilic Syndrome / genetics*
Hypereosinophilic Syndrome / mortality*
Kaplan-Meier Estimate
Male
Middle Aged
Retrospective Studies
Young Adult